Media & Resources

A team of researchers at The Scripps Research Institute (TSRI) and IAVI report in the current issue of Science a novel strategy to aid the design of vaccines that can elicit broadly neutralizing antibodies against HIV. Their approach, which applies pioneering computational and genetic engineering techniques to create an HIV immunogen—the active ingredient of a…

The International AIDS Vaccine Initiative (IAVI) congratulates Marijke Wijnroks, member of IAVI’s Board of Directors, on her appointment as Chief of Staff at the Global Fund to Fight AIDS, Tuberculosis and Malaria. Dr. Wijnroks has a long track record of leadership in the global fight against HIV/AIDS, and a strong commitment to prioritizing Sexual Reproductive…

IAVI welcomes news that the Government of Japan has awarded the 2013 Hideyo Noguchi Africa Prize to two leaders of the global campaign to address the suffering caused by AIDS and end the HIV pandemic: Dr. Alex Coutinho, Executive Director of the Infectious Diseases Institute in Kampala, Uganda, and Dr. Peter Piot, Director of the…

Women the world over have made enormous progress in obtaining the right to lead their lives as they choose. IAVI applauds that progress and lends its unequivocal support to the continuing struggle to ensure equal rights and protections for all women, everywhere. Addressing the HIV epidemic among women is a big part of that struggle.…

IAVI is very pleased to share some important news regarding the new appointments of two highly-valued, integral senior staff in our Medical Affairs Department. Pat Fast, most recently Chief Medical Officer at IAVI, has transitioned into the role ofSenior Technical Advisor in Research and Development, effective February 1, 2013.  Pat will have specific responsibilities in IAVI’s…

Prototype candidate and potential new method to help prevent infection via broadly neutralizing antibodies will be assessed for safety, tolerability, durability NEW YORK – IAVI, the International AIDS Vaccine Initiative, today announced the start of a Phase I clinical trial in the U.K. examining a prototype candidate and a potential new method to prevent HIV infection.…

Although antiretroviral treatment and current prevention options have considerably reduced HIV infections and AIDS-related deaths, a safe and effective vaccine is needed to end the global AIDS pandemic expeditiously and sustainably, according to a new commentary from Anthony S. Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the…

Proof-of-concept for vaccine candidate that can elicit broadly neutralizing antibodies could be applied to HIV, other challenging viruses NEW YORK – IAVI, the International AIDS Vaccine Initiative, congratulates researchers at The Scripps Research Institute (TSRI) for successfully employing new “designer proteins” to create a vaccine that, in preclinical studies, was shown to  elicit broadly neutralizing…